piretanide has been researched along with Hypertension in 37 studies
piretanide: potent inhibitor of chloride transport; structure
Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To test the dose responses of piretanide, ramipril, and their combination in patients with essential hypertension, a prospective, randomized, double-blind, placebo-controlled trial was conducted in 480 patients." | 9.07 | Usefulness of piretanide plus ramipril for systemic hypertension: a multicenter trial. ( Faulhaber, HD; Homuth, V; Löffler, K; Loose, U; Luft, FC, 1993) |
| "In a randomized, double-blind parallel group study the 24-hour hypotensive effect of piretanide and its influence on biochemical variables were compared with those of placebo in patients with mild to moderate essential hypertension." | 9.06 | Piretanide in the treatment of essential hypertension. A double-blind comparison versus placebo. ( Beloso, M; Bender, R; Garduno, D; Maass, L; Rangoonwala, B; Verho, M, 1986) |
| "A multi-centre, randomized, double-blind, parallel group study was undertaken in order to assess efficacy and tolerability of ramipril as compared to enalapril in mild to moderate hypertension." | 9.06 | A multi-centre comparative study between ramipril and enalapril in patients with mild to moderate essential hypertension. ( Akbary, MA; Rangoonwala, B; Rosenfeld, J; Schinzel, S; Zabludowski, J, 1988) |
| "A double-blind crossover study was carried out in 20 patients with mild to moderate essential hypertension to assess the efficacy and tolerability of a low fixed-dose combination containing 20 mg penbutolol (a beta-blocking agent) and 3 mg piretanide (a diuretic) in comparison to placebo over a period of 4 weeks." | 9.06 | Efficacy of a low fixed-dose combination of penbutolol with piretanide in the treatment of mild to moderate hypertension: a double-blind study against placebo. ( Rangoonwala, B; Verho, M; Yasky, J, 1986) |
| "The antihypertensive efficacy and tolerability of a fixed-dose combination containing 40 mg penbutolol (a beta-blocking agent) and 6 mg piretanide (a diuretic) in comparison to placebo was investigated in a double-blind, crossover study in 20 patients with mild to moderate essential hypertension." | 9.06 | Efficacy of a fixed-dose combination of 40 mg penbutolol with 6 mg piretanide in the treatment of mild to moderate hypertension: a double-blind study against placebo. ( Rangoonwala, B; Verho, M; Yasky, J, 1987) |
| "A double-blind trial was carried out in three parallel groups of patients with mild to moderate hypertension to assess the efficacy and tolerance of piretanide given as a single dose of 3 mg, 6 mg or 12 mg per day over a period of 12 weeks." | 9.05 | A double-blind study of piretanide in the treatment of hypertension. ( Dols, W; Freude, J; Rangoonwala, B; Verho, M, 1983) |
| "The efficacy and tolerability of penbutolol alone and in combination with piretanide at two dose levels were investigated in a double-blind parallel group study in patients with mild to moderate essential hypertension." | 9.05 | Efficacy of penbutolol + piretanide combinations in the treatment of arterial hypertension. ( Freude, J; Häringer, E; Pahnke, K; Rangoonwala, B; Verho, M, 1985) |
| "The metabolic effects of piretanide (2 x 6 mg daily) were compared with those of hydrochlorothiazide, in doses of 2 x 25 mg or 2 x 50 mg daily, in a double-blind study consisting of three parallel groups totalling 15 patients with uncomplicated essential hypertension." | 9.05 | The effects of piretanide on catecholamine metabolism, plasma renin activity and serum aldosterone: a double-blind pilot comparison against hydrochlorothiazide in patients with essential hypertension. ( Bückert, C; Kirsten, R; Verho, M, 1984) |
| "In a randomised double blind study in patients with mild to moderate hypertension, piretanide 6 mg once and twice daily significantly reduced both supine and erect blood pressure." | 9.05 | Single and divided daily dose piretanide in the treatment of uncomplicated essential hypertension: a double-blind comparison with a combination of hydrochlorothiazide and amiloride. ( Dols, W; Rangoonwala, B; Verho, M, 1985) |
| "In a randomized, double blind, parallel group study in out patients with mild to moderate essential hypertension the effects of piretanide on serum electrolytes and on blood pressure were compared with those of triamterene alone and the combination piretanide + triamterene." | 9.05 | Piretanide, a potassium stable diuretic, in the treatment of essential hypertension. ( Dols, W; Fratzer, U; Kaczynski, J; Mühlhäusler, W; Rangoonwala, B; Verho, M, 1984) |
| "A double-blind study was carried out in two parallel groups of patients with mild to moderate hypertension to assess the efficacy and tolerance of the combination 20 mg penbutolol plus 3 mg piretanide in comparison to 40 mg penbutolol alone over a period of 6 weeks." | 9.05 | Efficacy of penbutolol and a combination of a low dose of penbutolol with piretanide in the treatment of mild to moderate hypertension. ( Englert, R; Graml, E; Häringer, E; Pahnke, K; Rangoonwala, B; Verho, M, 1985) |
| "In a randomized double-blind parallel group study the effects of two formulations of piretanide (standard tablet and slow-release capsule) were compared in patients with mild to moderate essential hypertension." | 9.05 | Piretanide, a potassium stable diuretic, in the treatment of essential hypertension: a double-blind comparison of two formulations. ( Dols, W; Jaeger, S; Rangoonwala, B; Verho, M, 1985) |
| "A single-blind study was carried out in 22 out-patients with mild to moderate hypertension to investigate the effects of piretanide capsules on systolic and diastolic blood pressure during standardized ergometric and isometric exercise." | 7.67 | The effects of piretanide capsules on blood pressure during ergometric and isometric work loads in patients with mild to moderate essential hypertension. ( Maass, L; Meywald, W; Rangoonwala, B; Verho, M, 1985) |
| "Piretanide presented in 6 mg sustained-release capsules was administered twice daily for 12 weeks as antihypertensive monotherapy to 16 patients with mild-to-moderate hypertension." | 7.66 | Piretanide in the treatment of hypertension. Effects on arterial blood pressure and several blood variables. ( Leary, WP; Reyes, AJ, 1981) |
| " The purpose of the present study was to examine whether long-term therapy with ramipril (RA, and ACE inhibitor) would lower blood pressure more effectively and without adverse reactions in combination with the loop diuretics piretanide (PI) or furosemide (FU)." | 5.28 | Loop diuretics combined with an ACE inhibitor for treatment of hypertension: a study with furosemide, piretanide, and ramipril in spontaneously hypertensive rats. ( Baldes, L; Becker, RH; Treudler, M, 1989) |
| "To test the dose responses of piretanide, ramipril, and their combination in patients with essential hypertension, a prospective, randomized, double-blind, placebo-controlled trial was conducted in 480 patients." | 5.07 | Usefulness of piretanide plus ramipril for systemic hypertension: a multicenter trial. ( Faulhaber, HD; Homuth, V; Löffler, K; Loose, U; Luft, FC, 1993) |
| "The antihypertensive efficacy and tolerability of a fixed-dose combination containing 40 mg penbutolol (a beta-blocking agent) and 6 mg piretanide (a diuretic) in comparison to placebo was investigated in a double-blind, crossover study in 20 patients with mild to moderate essential hypertension." | 5.06 | Efficacy of a fixed-dose combination of 40 mg penbutolol with 6 mg piretanide in the treatment of mild to moderate hypertension: a double-blind study against placebo. ( Rangoonwala, B; Verho, M; Yasky, J, 1987) |
| "In a randomized, double-blind parallel group study the 24-hour hypotensive effect of piretanide and its influence on biochemical variables were compared with those of placebo in patients with mild to moderate essential hypertension." | 5.06 | Piretanide in the treatment of essential hypertension. A double-blind comparison versus placebo. ( Beloso, M; Bender, R; Garduno, D; Maass, L; Rangoonwala, B; Verho, M, 1986) |
| "The haemodynamic effects of piretanide, acebutolol and nifedipine were tested and compared at rest and on exercise in an open study of patients with essential hypertension, grade II (WHO)." | 5.06 | [Modification of resting and effort hemodynamics in essential arterial hypertension using antihypertensive agents]. ( Wiechmann, HW, 1987) |
| "A double-blind crossover study was carried out in 20 patients with mild to moderate essential hypertension to assess the efficacy and tolerability of a low fixed-dose combination containing 20 mg penbutolol (a beta-blocking agent) and 3 mg piretanide (a diuretic) in comparison to placebo over a period of 4 weeks." | 5.06 | Efficacy of a low fixed-dose combination of penbutolol with piretanide in the treatment of mild to moderate hypertension: a double-blind study against placebo. ( Rangoonwala, B; Verho, M; Yasky, J, 1986) |
| "A double-blind parallel group study was carried out in patients with mild to moderate hypertension to assess the effects of 6 mg piretanide once or twice daily, in comparison to 50 mg hydrochlorothiazide plus 5 mg amiloride once daily, on serum trace-element levels over a period of three months." | 5.06 | Serum trace-element levels in piretanide-treated hypertensives: a double-blind trial against hydrochlorothiazide plus amiloride. ( Bossaller, W; Heinen, B; Verho, M, 1987) |
| "In a double-blind parallel group study carried out on 47 patients with mild to moderate essential hypertension, the effects of 6 mg piretanide once or twice daily on serum selenium levels were compared with 50 mg hydrochlorothiazide plus 5 mg amiloride before treatment and after 6 and 12 weeks of treatment." | 5.06 | Serum selenium levels in diuretic-treated hypertensives: a double-blind trial of piretanide against hydrochlorothiazide plus amiloride. ( Bossaller, W; Malerczyk, V; Verho, M, 1988) |
| "A multi-centre, randomized, double-blind, parallel group study was undertaken in order to assess efficacy and tolerability of ramipril as compared to enalapril in mild to moderate hypertension." | 5.06 | A multi-centre comparative study between ramipril and enalapril in patients with mild to moderate essential hypertension. ( Akbary, MA; Rangoonwala, B; Rosenfeld, J; Schinzel, S; Zabludowski, J, 1988) |
| "The metabolic effects of piretanide (2 x 6 mg daily) were compared with those of hydrochlorothiazide, in doses of 2 x 25 mg or 2 x 50 mg daily, in a double-blind study consisting of three parallel groups totalling 15 patients with uncomplicated essential hypertension." | 5.05 | The effects of piretanide on catecholamine metabolism, plasma renin activity and serum aldosterone: a double-blind pilot comparison against hydrochlorothiazide in patients with essential hypertension. ( Bückert, C; Kirsten, R; Verho, M, 1984) |
| "In a randomized, double blind, parallel group study in out patients with mild to moderate essential hypertension the effects of piretanide on serum electrolytes and on blood pressure were compared with those of triamterene alone and the combination piretanide + triamterene." | 5.05 | Piretanide, a potassium stable diuretic, in the treatment of essential hypertension. ( Dols, W; Fratzer, U; Kaczynski, J; Mühlhäusler, W; Rangoonwala, B; Verho, M, 1984) |
| "In a randomized double-blind parallel group study the effects of two formulations of piretanide (standard tablet and slow-release capsule) were compared in patients with mild to moderate essential hypertension." | 5.05 | Piretanide, a potassium stable diuretic, in the treatment of essential hypertension: a double-blind comparison of two formulations. ( Dols, W; Jaeger, S; Rangoonwala, B; Verho, M, 1985) |
| "A double-blind study was carried out in two parallel groups of patients with mild to moderate hypertension to assess the efficacy and tolerance of the combination 20 mg penbutolol plus 3 mg piretanide in comparison to 40 mg penbutolol alone over a period of 6 weeks." | 5.05 | Efficacy of penbutolol and a combination of a low dose of penbutolol with piretanide in the treatment of mild to moderate hypertension. ( Englert, R; Graml, E; Häringer, E; Pahnke, K; Rangoonwala, B; Verho, M, 1985) |
| "In a randomised double blind study in patients with mild to moderate hypertension, piretanide 6 mg once and twice daily significantly reduced both supine and erect blood pressure." | 5.05 | Single and divided daily dose piretanide in the treatment of uncomplicated essential hypertension: a double-blind comparison with a combination of hydrochlorothiazide and amiloride. ( Dols, W; Rangoonwala, B; Verho, M, 1985) |
| "The efficacy and tolerability of penbutolol alone and in combination with piretanide at two dose levels were investigated in a double-blind parallel group study in patients with mild to moderate essential hypertension." | 5.05 | Efficacy of penbutolol + piretanide combinations in the treatment of arterial hypertension. ( Freude, J; Häringer, E; Pahnke, K; Rangoonwala, B; Verho, M, 1985) |
| "A double-blind trial was carried out in three parallel groups of patients with mild to moderate hypertension to assess the efficacy and tolerance of piretanide given as a single dose of 3 mg, 6 mg or 12 mg per day over a period of 12 weeks." | 5.05 | A double-blind study of piretanide in the treatment of hypertension. ( Dols, W; Freude, J; Rangoonwala, B; Verho, M, 1983) |
| "The effect of antihypertensive treatment with 6-12 mg of the loop diuretic piretanide over 12 weeks on Na+-Li+ countertransport, and on extra- and intracellular electrolyte composition was studied in 10 previously untreated patients with essential hypertension." | 3.67 | Na+-Li+ countertransport and electrolyte composition in erythrocytes of patients with essential hypertension before and after antihypertensive treatment. ( Beuckelmann, D; Erdmann, E, 1986) |
| "The effect of a new diuretic, piretanide, on glucose tolerance, insulin secretion and 125I-insulin binding to erythrocytes was studied in 12 male patients with mild essential hypertension." | 3.67 | Effects of a new diuretic piretanide on glucose tolerance, insulin secretion and 125I-insulin binding. ( Harno, K; Välimäki, M; Verho, M, 1985) |
| "Intra-arterial blood pressure (IABP), baroreflex sensitivity and set point were measured in nine patients with essential hypertension during a control period and then after acute (4 h after a 12 mg oral dose) and chronic (after 3 months) treatment with the loop diuretic piretanide, mean dose 10 mg." | 3.67 | Acute and chronic effects of the loop diuretic, piretanide, on baroreflex set point and sensitivity in hypertensive man. ( Littler, WA; Watson, RD; Young, MA, 1985) |
| "A single-blind study was carried out in 22 out-patients with mild to moderate hypertension to investigate the effects of piretanide capsules on systolic and diastolic blood pressure during standardized ergometric and isometric exercise." | 3.67 | The effects of piretanide capsules on blood pressure during ergometric and isometric work loads in patients with mild to moderate essential hypertension. ( Maass, L; Meywald, W; Rangoonwala, B; Verho, M, 1985) |
| "Piretanide presented in 6 mg sustained-release capsules was administered twice daily for 12 weeks as antihypertensive monotherapy to 16 patients with mild-to-moderate hypertension." | 3.66 | Piretanide in the treatment of hypertension. Effects on arterial blood pressure and several blood variables. ( Leary, WP; Reyes, AJ, 1981) |
| " Eumagnesaemia and eupotassaemia were preserved at all dosage of the piretanide monosubstance." | 2.66 | Lack of effect of piretanide (a potassium-stable diuretic) on serum magnesium. ( de Looze, S; Irmisch, R; Rangoonwala, B; Verho, M, 1987) |
| "Piretanide is a potent 'loop' diuretic whose principal site of action is in the thick ascending limb of the loop of Henle." | 2.37 | Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. ( Brogden, RN; Clissold, SP, 1985) |
| " HPC-EC10 (5:3) microcapsules containing piretanide were satisfactory as a sustained-release preparation in the light of the anti hypertensive effect even at a half frequency of daily dosing of the solution." | 1.28 | Pharmacological evaluation of hydroxypropylcellulose-ethylcellulose microcapsules containing piretanide. ( Goto, S; Kawata, M; Kuriki, T; Suzuki, N; Tsujiyama, T, 1990) |
| " The purpose of the present study was to examine whether long-term therapy with ramipril (RA, and ACE inhibitor) would lower blood pressure more effectively and without adverse reactions in combination with the loop diuretics piretanide (PI) or furosemide (FU)." | 1.28 | Loop diuretics combined with an ACE inhibitor for treatment of hypertension: a study with furosemide, piretanide, and ramipril in spontaneously hypertensive rats. ( Baldes, L; Becker, RH; Treudler, M, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 31 (83.78) | 18.7374 |
| 1990's | 5 (13.51) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (2.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Musini, VM | 1 |
| Rezapour, P | 1 |
| Wright, JM | 1 |
| Bassett, K | 1 |
| Jauca, CD | 1 |
| Dols, W | 4 |
| Freude, J | 2 |
| Verho, M | 16 |
| Rangoonwala, B | 12 |
| Buckert, C | 2 |
| Muhlhausler, W | 2 |
| Fratzer, U | 2 |
| Kirsten, R | 1 |
| Kaczynski, J | 1 |
| Zidek, W | 3 |
| Losse, H | 3 |
| Schmidt, W | 1 |
| Fehske, KJ | 2 |
| Vetter, H | 3 |
| Baumgart, P | 2 |
| Karoff, C | 2 |
| Radaelli, L | 1 |
| Cosci, P | 1 |
| Grillo, C | 1 |
| Bertoli, S | 1 |
| Minetti, L | 1 |
| Leary, WP | 1 |
| Reyes, AJ | 1 |
| Thijs, L | 1 |
| Celis, H | 1 |
| Kiowski, W | 1 |
| Löffler, K | 2 |
| Middeke, M | 1 |
| Schulz, W | 1 |
| Staessen, J | 1 |
| Amery, A | 1 |
| Bellaïche, G | 1 |
| Lamouri, N | 1 |
| Slama, JL | 1 |
| Ley, G | 1 |
| Paugam, B | 1 |
| Homuth, V | 1 |
| Faulhaber, HD | 1 |
| Loose, U | 1 |
| Luft, FC | 1 |
| Tsujiyama, T | 1 |
| Suzuki, N | 1 |
| Kuriki, T | 1 |
| Kawata, M | 1 |
| Goto, S | 1 |
| Becker, RH | 1 |
| Baldes, L | 1 |
| Treudler, M | 1 |
| Zabludowski, J | 1 |
| Rosenfeld, J | 1 |
| Akbary, MA | 1 |
| Schinzel, S | 1 |
| Häcker, W | 1 |
| Bossaller, W | 2 |
| Malerczyk, V | 1 |
| Wiechmann, HW | 2 |
| Heinen, B | 1 |
| Irmisch, R | 1 |
| de Looze, S | 1 |
| Beloso, M | 1 |
| Maass, L | 2 |
| Bender, R | 1 |
| Garduno, D | 1 |
| Yasky, J | 2 |
| Beuckelmann, D | 1 |
| Erdmann, E | 1 |
| Jaeger, S | 1 |
| Harno, K | 1 |
| Välimäki, M | 1 |
| Clissold, SP | 1 |
| Brogden, RN | 1 |
| Graml, E | 1 |
| Englert, R | 1 |
| Häringer, E | 2 |
| Pahnke, K | 2 |
| Meyer, BH | 1 |
| Müller, FO | 1 |
| Werkman, IM | 1 |
| Luus, HG | 1 |
| Lötter, MG | 1 |
| Grigoleit, HG | 1 |
| Young, MA | 1 |
| Watson, RD | 1 |
| Littler, WA | 1 |
| Scholz, W | 1 |
| Hropot, M | 1 |
| Meywald, W | 1 |
2 reviews available for piretanide and Hypertension
| Article | Year |
|---|---|
Blood pressure-lowering efficacy of loop diuretics for primary hypertension.
Topics: Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Furosemide; Humans; Hyper | 2015 |
Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
Topics: Angina Pectoris; Animals; Blood Glucose; Diuretics; Dogs; Edema; Heart Failure; Humans; Hypertension | 1985 |
21 trials available for piretanide and Hypertension
| Article | Year |
|---|---|
A double-blind study of piretanide in the treatment of hypertension.
Topics: Adult; Aged; Blood Pressure; Body Weight; Clinical Trials as Topic; Diuretics; Double-Blind Method; | 1983 |
A double-blind multicentre study of piretanide and hydrochlorothiazide in patients with essential hypertension.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Diuretics; Double-Blind Method; Female; Human | 1984 |
The effects of piretanide on catecholamine metabolism, plasma renin activity and serum aldosterone: a double-blind pilot comparison against hydrochlorothiazide in patients with essential hypertension.
Topics: Aged; Aldosterone; Blood Pressure; Catecholamines; Diuretics; Dopamine; Double-Blind Method; Female; | 1984 |
Piretanide, a potassium stable diuretic, in the treatment of essential hypertension.
Topics: Adult; Aged; Blood Pressure; Body Weight; Calcium; Clinical Trials as Topic; Diuretics; Double-Blind | 1984 |
Double-blind comparison of antihypertensive treatment with ramipril and piretanide, given alone or in combination.
Topics: Adult; Aged; Antihypertensive Agents; Blood Chemical Analysis; Blood Pressure; Diuretics; Double-Bli | 1995 |
Usefulness of piretanide plus ramipril for systemic hypertension: a multicenter trial.
Topics: Adult; Aged; Blood Pressure; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug | 1993 |
A multi-centre comparative study between ramipril and enalapril in patients with mild to moderate essential hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Diuretics; | 1988 |
Intracellular sodium and calcium during antihypertensive treatment.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Body Fluids; Calcium; Erythrocytes; Humans; Hype | 1985 |
Serum selenium levels in diuretic-treated hypertensives: a double-blind trial of piretanide against hydrochlorothiazide plus amiloride.
Topics: Adult; Aged; Amiloride; Clinical Trials as Topic; Diuretics; Double-Blind Method; Humans; Hydrochlor | 1988 |
[Hemodynamic effects of different antihypertensive combinations].
Topics: Acebutolol; Antihypertensive Agents; Captopril; Chronic Disease; Diuretics; Drug Evaluation; Drug Th | 1988 |
Serum trace-element levels in piretanide-treated hypertensives: a double-blind trial against hydrochlorothiazide plus amiloride.
Topics: Adult; Aged; Amiloride; Clinical Trials as Topic; Diuretics; Double-Blind Method; Humans; Hydrochlor | 1987 |
Lack of effect of piretanide (a potassium-stable diuretic) on serum magnesium.
Topics: Amiloride; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; | 1987 |
Piretanide in the treatment of essential hypertension. A double-blind comparison versus placebo.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Diuretics; Double-Blind Method; Drug Administ | 1986 |
Efficacy of a fixed-dose combination of 40 mg penbutolol with 6 mg piretanide in the treatment of mild to moderate hypertension: a double-blind study against placebo.
Topics: Adult; Aged; Blood Pressure; Circadian Rhythm; Clinical Trials as Topic; Diuretics; Double-Blind Met | 1987 |
[Modification of resting and effort hemodynamics in essential arterial hypertension using antihypertensive agents].
Topics: Acebutolol; Antihypertensive Agents; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; | 1987 |
Efficacy of a low fixed-dose combination of penbutolol with piretanide in the treatment of mild to moderate hypertension: a double-blind study against placebo.
Topics: Adult; Circadian Rhythm; Diuretics; Double-Blind Method; Drug Combinations; Exercise Test; Female; H | 1986 |
Piretanide, a potassium stable diuretic, in the treatment of essential hypertension: a double-blind comparison of two formulations.
Topics: Adult; Aged; Blood Pressure; Capsules; Clinical Trials as Topic; Delayed-Action Preparations; Diuret | 1985 |
Piretanide for hypertension.
Topics: Clinical Trials as Topic; Diuretics; Humans; Hypertension; Magnesium; Potassium; Sulfonamides | 1985 |
Efficacy of penbutolol and a combination of a low dose of penbutolol with piretanide in the treatment of mild to moderate hypertension.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combinatio | 1985 |
Single and divided daily dose piretanide in the treatment of uncomplicated essential hypertension: a double-blind comparison with a combination of hydrochlorothiazide and amiloride.
Topics: Adult; Aged; Amiloride; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Fe | 1985 |
Efficacy of penbutolol + piretanide combinations in the treatment of arterial hypertension.
Topics: Adult; Blood Chemical Analysis; Blood Pressure; Body Weight; Clinical Trials as Topic; Diuretics; Dr | 1985 |
14 other studies available for piretanide and Hypertension
| Article | Year |
|---|---|
[Study report: Hypertension therapy with organ protection. Piretanid and Ramipril: advantages with fixed combination].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diuretics; Humans; Hypertension; | 1994 |
Intracellular electrolytes during antihypertensive treatment with a loop diuretic.
Topics: Adult; Aged; Diuretics; Erythrocytes; Female; Humans; Hypertension; Male; Middle Aged; Potassium; So | 1984 |
Intracellular calcium in essential hypertension. A parameter for assessing effective antihypertensive treatment.
Topics: Adult; Aged; Animals; Blood Pressure; Blood Volume; Calcium; Diuretics; Drug Evaluation; Drug Evalua | 1984 |
[Evaluation of the antihypertensive effect of the new saluretic drug, piretanide].
Topics: Adult; Diuretics; Electrolytes; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Sulfo | 1982 |
Piretanide in the treatment of hypertension. Effects on arterial blood pressure and several blood variables.
Topics: Adult; Aged; Blood Pressure; Delayed-Action Preparations; Diuretics; Drug Evaluation; Electrolytes; | 1981 |
[Cytolytic hepatic lesion associated with the ingestion of piretanide].
Topics: Aged; Chemical and Drug Induced Liver Injury; Diuretics; Female; Humans; Hypertension; Liver Functio | 1995 |
Pharmacological evaluation of hydroxypropylcellulose-ethylcellulose microcapsules containing piretanide.
Topics: Administration, Oral; Aldosterone; Animals; Blood Pressure; Body Weight; Cellulose; Diuretics; Drug | 1990 |
Loop diuretics combined with an ACE inhibitor for treatment of hypertension: a study with furosemide, piretanide, and ramipril in spontaneously hypertensive rats.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Bridged | 1989 |
Na+-Li+ countertransport and electrolyte composition in erythrocytes of patients with essential hypertension before and after antihypertensive treatment.
Topics: Adult; Diuretics; Erythrocytes; Female; Humans; Hypertension; Lithium; Male; Middle Aged; Sodium; Su | 1986 |
Effects of a new diuretic piretanide on glucose tolerance, insulin secretion and 125I-insulin binding.
Topics: Adult; Blood Glucose; C-Peptide; Diuretics; Glucagon; Glucose Tolerance Test; Humans; Hypertension; | 1985 |
Effects of piretanide on potassium balance in hypertension.
Topics: Adult; Aged; Diuretics; Female; Humans; Hypertension; Male; Middle Aged; Potassium; Sulfonamides | 1985 |
Acute and chronic effects of the loop diuretic, piretanide, on baroreflex set point and sensitivity in hypertensive man.
Topics: Adult; Blood Pressure; Diuretics; Drug Evaluation; Drug Resistance; Female; Heart Rate; Humans; Hype | 1985 |
Na+-K+ cotransport and hypertension. Effect of piretanide and hydrochlorothiazide on red blood cell sodium concentration in acutely salt-loaded hypertensive and normotensive rats.
Topics: Animals; Biological Transport; Diuretics; Erythrocytes; Hydrochlorothiazide; Hypertension; Male; Pot | 1985 |
The effects of piretanide capsules on blood pressure during ergometric and isometric work loads in patients with mild to moderate essential hypertension.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Capsules; Cholesterol; Creatinine; Diuretics; Female; Hu | 1985 |